Daiken Biomedical Co., Ltd. (7780.TW) stock: key figures, P/E, revenue and dividend

Consumer Staples · Taiwan

Price
15.05 TWD
Market cap
12.19 bn TWD
P/E (2025)
36.08
P/S (2025)
6.43
Dividend yield
7.27 %
Net margin
17.83 %
Return on equity (ROE)
6.21 %
Return on assets (ROA)
5.71 %

Daiken Biomedical Co., Ltd. financials

Fiscal year20242025
Revenue1.36 bn TWD1.90 bn TWD
Gross profit856.22 m TWD1.21 bn TWD
Operating income149.80 m TWD288.24 m TWD
EBIT145.60 m TWD418.08 m TWD
Net income106.58 m TWD337.87 m TWD
Diluted EPS – continuing operations1.78 TWD0.42 TWD

Full history since 2022, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Daiken Biomedical Co., Ltd.

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.